Enzymatic production of optically pure (2′R-cis)-2′-deoxy-3′-thiacytidine (3TC, lamivudine): A potent anti-HIV agent
- 1 September 1993
- journal article
- Published by Elsevier in Enzyme and Microbial Technology
- Vol. 15 (9) , 749-755
- https://doi.org/10.1016/0141-0229(93)90005-m
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- (-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitroAntimicrobial Agents and Chemotherapy, 1992
- Synthesis of enantiomerically pure (2'R,5'S)-(-)-1-(2-hydroxymethyloxathiolan-5-yl)cytosine as a potent antiviral agent against hepatitis B virus (HBV) and human immunodeficiency virus (HIV)The Journal of Organic Chemistry, 1992
- Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytesAntimicrobial Agents and Chemotherapy, 1992
- An efficient synthesis of enantiomerically pure (+)-(2S,5R)-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine [(+)-BCH-189] from d-galactoseTetrahedron Letters, 1992
- The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitroAntimicrobial Agents and Chemotherapy, 1992
- Enantiomeric synthesis of (+)-BCH-189 [(+)-(2S,5R)-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine] from D-mannose and its anti-HIV activityThe Journal of Organic Chemistry, 1991
- Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analogAntimicrobial Agents and Chemotherapy, 1991
- Recent Advances in the Generation of Chiral Intermediates Using EnzymesCritical Reviews in Biotechnology, 1990
- Synthesis and enzymatic resolution of carbocyclic 2′-ara-fluoro-guanosine: a potent new anti-herpetic agentJournal of the Chemical Society, Chemical Communications, 1988
- Tetrahedron report number 203Tetrahedron, 1986